Efficacy of Polimyxin B immobilized fiber column direct hemoperfusion:A prospective study

Efficacy of Polimyxin B immobilized fiber column direct hemoperfusion:A prospective study - Mie PMX study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022088

Enrollment

Registered

2016-05-01

Start date

2016-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock,ARDS,interstitial pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1: endotoxemia or Gram-negative bacillus infection suspected 2: A-D at the same time two or more items A: body temperature is more than 38 degrees or less than 36 degrees B: heart rate is more than 90/min C: respiratory rate is more than 20/min,less than PaCO2 32 mmHg D: white blood cell count is more than 12000/mm3, or less than 4000/mm3 3: septic shock

Exclusion criteria

Exclusion criteria: A: patients with underlying disease that is considered to ensure death within a week B: malignant disease C: high risk of bleeding cases D: combination with other investigational drugs E: judged unsuitable for this survey F: not obtained consent from the person or agent G: minors

Design outcomes

Primary

Measure	Time frame
To examine the absorbed materials of PMX therapy	—

Secondary

Measure	Time frame
Survival rate at 28 days after ICU admission	—

Countries

Japan

Contacts

Public ContactMika Fujimoto

Mie University Graduate School of Medicine Department of Cardiology and Nephrology

mikagoto125416@yahoo.co.jp059-231-5015

Outcome results